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第一部分  地牡宁神口服液治疗儿童 ADHD 有效性研究 
目的 





and Statistical Manual of Mental Disorders, Fourth Edition,DSM-IV)中儿
童 ADHD 诊断，又符合中医辨证属于阴虚阳亢证诊断，年龄为 3~16 岁，共计 182
例。分两个 3~5、6~14 年龄层，3~5 岁年龄层采用自身前后对照设计；6~14 岁年
龄层采用随机对照临床试验设计，随机分为地牡宁神口服液组（研究组）和哌甲
酯控释片组（对照组）。 





（1）3~5 年龄层地牡宁神口服液组结果显示：在第 24 周，PSQ 中的 6 个观
察因子较治疗前评分均有降低，且差异显著（P<0.05）。 
（2）6~14 年龄层：地牡宁神口服液组（研究组）及哌甲酯控释片组（对照
组），在第 24 周的评估中，SNAP-IV 量表之核心症状分量表评分，组内比较，
均低于治疗前（P<0.05）；第 8、16 周、24 周 SNAP-IV 量表之核心总分，两组
组间，第 8 周，研究组高于于对照组（P<0.05）；研究组第 8 周、16 周、24 周




















（1）3~5 年龄层地牡宁神口服液组结果显示：在第 8 周、16 周、24 周,中
医证候主、次症积分、及总积分均低于治疗前（P<0.05）。按中医证候疗效判定
标准，第 8 周、16 周、24 周总有效率分别为 61.29%、80.65%、83.87%。 
3.其他评估项目疗效结果 
（1）3~5 年龄层地牡宁神口服液组结果显示： 



































第二部分  地牡宁神口服液治疗儿童 ADHD 安全性研究 
目的 
注意缺陷多动障碍儿童服用地牡宁神口服液治疗 24 周,评价其安全性。 
方法 
在治疗前及治疗 24 周后对 ADHD 儿童心电图、血常规、血生化（肝肾功能）
各检查一次，并记录治疗期间出现的不良反应。 
结果 
1. 3~5 岁地牡宁神口服液（研究组）安全性结果 
 3~5 岁年研究组治疗前后未见严重不良反应发生。血常规、血生化及心电
图皆无明显变化（P>0.05)。改组共计 4 例儿童出现不良反应，总发生率为约 13%。
2 例（6.5%）儿童出现疲倦、嗜睡，1 例（3.2%）儿童出现口腔溃疡，1 例（3.2%）
儿童出现腹泻，上述副反应均为轻度或可疑。 
2. 4~16 岁年龄层两组群体安全性结果 
4~16岁年龄层两组群体治疗前后血常规、血生化及心电图皆无明显变化（P>0. 
05)。未出现严重不良反应。地牡宁神口服液组共计 2 例儿童出现嗜睡的不良反
应，总发生率为约 3.1%。哌甲酯控释片组不良反应者共计 18 例，发生率为 29%，
























Part 1  An efficacy study on Dimu Ningshen Koufuye which was 
used to treat ADHD 
AIM 
Research to Dimu Ningshen Koufuye for the treatment of attention deficit 
hyperactivity disorder in children, Looking for traditional Chinese medicine treatment 
of evidence of the effectiveness of ADHD children. 
METHODS 
1. The research object not only conforms to the fourth edition of the diagnostic 
and statistical manual of mental disorders of the diagnosis, and conform to the 
traditional Chinese medicine diagnos Age range from3years old to 16 years old, a 
total of 182 samples, the actual 157 sample use is to study. This study is divided into 
3~5 years old and 6~14 years old two ages.The samples of 3~5years old ages 
designed its contrast before and after the treatment.Samples of 6~14 years old ages 
using randomized controlled clinical trial design, were randomly divided into 
experimental group and control group.  
2. Curative effect evaluation: using SNAP-IV Conners parents with symptoms 
questionnaire (PSQ), wechsler intelligence scale and TCM syndrome to evaluate 
curative effect evaluation tool. 




 1.Clinical curative effect: 
    (1)Experimental results show: 3~5 ages at 24 weeks, six of PSQ observation 















(2)6~14 patients ages: the experimental group and control group, the SNAP in 24 
weeks - IV, according to the amount of core symptom scores within the group, scores 
are lower than before treatment (P<0.05); Each time point scale core symptom score, 
the SNAP to IV, between the two way in 8 weeks, the experimental group than in 
control group (P<0.05);  Experimental group each time point of efficient are 42.2%, 
67.2% and 42.2% respectively, the control effectiveness respectively is 61.3%, 66.1%, 
71.0%; Corresponding point effectiveness comparison between the two way, 8 weeks 
group effectiveness is lower than the control group (P<0.05). At 24 weeks, the 
evaluation of the Conners parents with symptoms questionnaire (PSQ) six factor score, 
two way in comparison, are lower than before treatment (P<0.05);Comparison 
between the two way, disabled factor score of experimental group is lower than the 
control group (P<0.05). 
2.Curative effect of traditional Chinese medicine 
Experimental research shows that: 3~5 ages in 8 weeks, 16 weeks and 24 weeks, 
the scores of traditional Chinese medicine are lower than before treatment (P<0.05). 
3~6years old group in 8 weeks, 16 weeks and 24 weeks total effective rate were 
61.29%, 80.65% and 83.87% respectively. 
2.Other project results 
(1)Experimental results show: 3 ~ 5 ages 
At 24 weeks, wechsler children's intelligence, according to the results of total 
intelligence quotient, perception reasoning, working memory, processing speed, are 
higher than the baseline points, significant difference (P<0.05). At 24 weeks, diet, 
sleep, the brain evoked potentials, eeg ZhengChangLv was higher, the the difference 
comparison before and after the treatment was not significant (P>0. 05). 
(2)6~14 age: 24 Zhou Wei's intelligence, according to the results of two groups 
of total intelligence quotient (IQ) and the synthetic index score, comparison group, the 
experimental group except verbal comprehension index, other differences were 
significantly (P<0.05); Control group in working memory, processing speed, cognitive 
efficiency and total IQ significantly higher than that of before treatment (P<0.05). 















general ability and total IQ improvement is better than that in control group (P<0.05). 
In the two groups in the diet, sleep, the brain evoked potential and 
electroencephalography (eeg), ZhengChangLv improvement in group, comparing 
differences between groups was not significant (P >0. 05). 
 
CONCLUSION 
1. Dimu Ningshen Koufuye can obviously improve the ADHD children of heart 
disease, its characteristic as pharmacokinetic compared to work slower, long-term 
medication effect is obvious, to the child guardian complete instructions, increase 
medication compliance. 
2.Dimu Ningshen Koufuye on improving sleep, diet, and functional enuresis 
children with ADHD has certain curative effect, to contract the disease ADHD 
children suggested that using the drug. 
3.Of TCM diagnosis of ADHD children, with Yin latent Yang, soothe the 
educational role, in the treatment of diseases of traditional Chinese medicine, improve 
intelligence effect better than pharmacokinetic. 

















Part 2  An safety study on Dimu Ningshen Koufuye which was used 
to treat ADHD 
AIM 
Attention deficit hyperactivity disorder childrenDimu Ningshen Koufuye 
treatment for 24 weeks, evaluate its safety. 
METHODS 
Before treatment and 24 weeks after treatment of ADHD children 
electrocardiogram (ECG), blood routine, blood biochemistry, liver and kidney 
function) the examination time, and record adverse reactions during the treatment. 
RESULTS 
1.3~5 years old group security results 
routine examination, blood biochemical examination and electrocardiogram 
examination are no significant change (P>0. 05).This group of a total of 4 cases of 
adverse reactions in their children, a total incidence of about 13%.In 2 cases (6.5%) 
children appear fatigue, sleepiness, 1 case (3.2%) children in oral ulcer, 1 case (3.2%) 
children diarrhea, the side effects were mild or suspicious. 
2. Two groups of 4 ~ 16 ages group security results 
electrocardiogram (ecg) were no significant changes (P>0. 05).Does not appear 
serious adverse reactions.Negundo ning god oral liquid for a total of 2 children appear 
sleepiness, adverse reactions, total incidence of about 3.1%.Ritalin retard-20 tablet 
group a total of 18 cases of adverse reaction, the incidence was 29%, its for 6 cases 
(9.7%), loss of appetite most, it is significantly higher than negundo ning god oral 
liquid (P <0.05). 
 
CONCLUSION 
Negundo ning god oral liquid treating children ADHD with no serious adverse 















ritalin retard-20 tablet, applicable to poor appetite, emaciation, or children were 
suffering from a sleep disorder. 
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英文缩写         中文全称                     英文全称 
ADHD         注意缺陷多动障碍            Attention Deficit/hyperactivity Disorder 
DSM-IV      《精神障碍诊断和统计手册》    Diagnostic and Statistical Manual of              
                   第四版                   Mental Disorders, Fourth Edition 
MBD          轻微脑功能失调               Minimal Brain Dysfhaction 
MTA         儿童多种模式治疗              Multimodal treatment study of children            
SNAP-IV     SNAP-Ⅳ评定量表              Version of Swanson Nolan and Pelham 
                                           Version IV Scale-parent form 
PSQ         Conners 父母用症状问卷         Parent Symptom Questionnaire 
WISC-IV    韦氏儿童智力量表第四版        Wechsler Intelligence Scale for Children 
FDA        美国食品和药品管理局           Food and Drug Administration 
PR-MPH    盐酸哌甲酯缓释片            Methylphenidate Hydrochloride Prolonged  
                                          Prolonged-Release Tablets      
ALT        谷丙转氨酶                    Alannine transaminase 
AST        谷草转氨酶                    Glutamic oxalacetic transaminase 
BUN        尿素氮                        Blood urea nitrogen 
PPS         符合方案数据集                Protocol population set 
SAS         安全性分析集                  Safety analysis set 














第一章  前 言 
  1
第一章 前言 
1.1 西医对 ADHD 的研究现状 
1.1.1 ADHD 简介 
注意缺陷多动障碍(Attention Deficit /Hyperactivity Disorder, ADHD )又称儿童多动
症,是儿童时期常见的一种神经发育障碍。其以注意缺陷、多动、冲动为三大核心症状，
亦常伴发学习困难、认知功能缺陷、社会功能损害等一系列问题，严重威胁着儿童的身
心健康。儿童少年 ADHD 有较高的患病率，Polanczyk G 等报道学龄期儿童 ADHD 发
病率约为 5%[1]，国内学龄期儿童患病率为 5%~10%[2]；有报道美国男童 ADHD 的患病
率是女童的 4~ 9 倍，国内报道男童则是女童的 3 倍[3]。ADHD 儿童的共病率高，约 65%
以上 ADHD 儿童共患一种或几种行为障碍，如品行障碍、对立违抗障碍、学习障碍、
睡眠障碍等[4]。ADHD 儿童的预后不容乐观，约 50%~70%[5]ADHD 儿童临床症状会延
续到成年期，对成人 ADHD 的学业、职业和生活等方面产生广泛而深远的消极影响[6],
因此，美国《精神障碍诊断和统计手册》第五版(Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition,DSM-V)，首次将成人ADHD诊断整合到儿童标准之中[7]，
受到精神病学界普遍关注。 

























素方面：Derks[10]等在对 6024 对双胞胎进行研究，得出 ADHD 的遗传率介于 32%~40%
之间；静进[11]报道，国内 ADHD 遗传率为 55%~92%，单卵双生子的发病率为 51%，双
卵双生子为 33%。Nyman[12]等通过出生队列分析,认为多巴胺 B 羟化酶(DBH)和多巴胺










1.1.3.2 ADHD 发病机制 
脑神经系统发育异常：ADHD 最早被称为“轻微脑功能失调”(Minimal Brain 
Dysfhaction,MBD），被认为大脑发育亦或受损伤导致该病的发生。随着神经影像学的
发展，有关学者开始对 ADHD 患者大脑结构及功能进行研究，发现 ADHD 患者大脑皮
层，尤其是前额叶皮质出现皮质厚度、偏侧化、白质连等发育异常，导致大脑发育出现
延迟，推断此现象是 ADHD 外在症状的神经基础[17-19]。Caromona S[20]等报道 ADHD 儿
童腹侧纹状体体积小于正常儿童，且与 ADHD 的核心症群状成负相关，推断腹侧纹状
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